NCT00195390View on ClinicalTrials.gov

Study Investigating Administration of Prevenar for Post-Marketing Surveillance

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

July 31, 2008

Conditions
Pneumococcal Infections
Interventions
BIOLOGICAL

Prevenar

Prevenar 0.5ml/ Vial and PFS

Trial Locations (1)

100-380

Seoul

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00195390 - Study Investigating Administration of Prevenar for Post-Marketing Surveillance | Biotech Hunter | Biotech Hunter